2020 - Preparing for FDA's New Import/Export Trauma in 2020
Date2020-03-19 - 2020-03-20
Deadline2020-03-09
VenueSan Francisco, CA, USA - United States
KeywordsFDA import regulations; CBP requirements; FDA import program
Topics/Call fo Papers
FDA’s new cost-saving import programs
Understand how U.S. Customs and FDA legal requirements intersect
Know how to manage foreign suppliers
Understand FDA’s internal procedures
Learn how to mitigate and resolve import detentions
Learn how to avoid common problems
Develop practical ways to improve your import and export business
You will be able to answer the following questions with this course without saying, “I don’t know?”
What are the FDA’s import legal requirements and policy?
How do you deal with the FDA and the U.S. Customs and Border Patrol procedures?
What happens when your product is detained?
What happens if a foreign manufacturer is in trouble with the FDA?
How do you inter-act with the FDA to work out problems?
Why are import and export rules different or does it even matter?
Understand how U.S. Customs and FDA legal requirements intersect
Know how to manage foreign suppliers
Understand FDA’s internal procedures
Learn how to mitigate and resolve import detentions
Learn how to avoid common problems
Develop practical ways to improve your import and export business
You will be able to answer the following questions with this course without saying, “I don’t know?”
What are the FDA’s import legal requirements and policy?
How do you deal with the FDA and the U.S. Customs and Border Patrol procedures?
What happens when your product is detained?
What happens if a foreign manufacturer is in trouble with the FDA?
How do you inter-act with the FDA to work out problems?
Why are import and export rules different or does it even matter?
Other CFPs
- A Comprehensive View of FDA Regulations for Medical Devices
- Navigating through Maze of In-vitro Diagnostics (IVD) Regulations: A systematic approach from Regulatory Strategy to Regulatory Approvals in U.S./Europe/Canada
- The Veterinary Drug Approval Process and FDA Regulatory Oversight
- Digital International Severe Asthma Forum (ISAF Digital 2020)
- Explore New SAMHSA Confidentiality Law for Substance Use Disorder Records(42 CFR Part 2)
Last modified: 2020-01-14 04:27:20